Centenial Surgical Suture has informed that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026, to approve Standalone Un-Audited Financial Results for the quarter & half year ended on September 30, 2026, pursuant to Regulation 33 of SEBI (LODR) Regulation, 2015; to consider the proposal for raising of funds by way of equity shares or any other securities through permissible modes, including but not limited to a rights issue or preferential issue or qualified institutions placement or any other method or a combination thereof, as may be permitted under applicable laws including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, and subject to receipt of regulatory / statutory / necessary approvals, as may be required; and any other business with the permission of chair.
The above information is a part of company’s filings submitted to BSE.
